The price of Guardant Health Inc (NASDAQ: GH) closed at $44.27 in the last session, down -0.34% from day before closing price of $44.42. In other words, the price has decreased by -$0.34 from its previous closing price. On the day, 1.74 million shares were traded. GH stock price reached its highest trading level at $44.895 during the session, while it also had its lowest trading level at $43.84.
Ratios:
We take a closer look at GH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 4.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $55.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $60.
Guggenheim Upgraded its Neutral to Buy on June 28, 2024, while the target price for the stock was maintained at $36.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 17 ’25 when Tariq Musa sold 116 shares for $48.20 per share. The transaction valued at 5,591 led to the insider holds 7,324 shares of the business.
POTTER MYRTLE S sold 26 shares of GH for $1,253 on Jul 17 ’25. The Director now owns 18,196 shares after completing the transaction at $48.20 per share. On Jul 17 ’25, another insider, Tariq Musa, who serves as the Director of the company, bought 116 shares for $48.20 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 5484521984 and an Enterprise Value of 6092334592. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.09. Its current Enterprise Value per Revenue stands at 7.871 whereas that against EBITDA is -14.763.
Stock Price History:
The Beta on a monthly basis for GH is 1.43, which has changed by 0.21989524 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $53.42, while it has fallen to a 52-week low of $20.14. The 50-Day Moving Average of the stock is -4.77%, while the 200-Day Moving Average is calculated to be 11.18%.
Shares Statistics:
According to the various share statistics, GH traded on average about 2.24M shares per day over the past 3-months and 1856900 shares per day over the past 10 days. A total of 123.65M shares are outstanding, with a floating share count of 117.75M. Insiders hold about 4.95% of the company’s shares, while institutions hold 96.53% stake in the company. Shares short for GH as of 1752537600 were 9582594 with a Short Ratio of 4.28, compared to 1749772800 on 9998417. Therefore, it implies a Short% of Shares Outstanding of 9582594 and a Short% of Float of 8.1199996.
